BeiGene
BGNE
#881
Rank
A$33.26 B
Marketcap
$302.96
Share price
1.71%
Change (1 day)
0.85%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Stock price history for BeiGene (BGNE)

Highest end of day price: $604.66 AUD on 2021-09-17

Lowest end of day price: $35.97 AUD on 2016-02-12

Stock price history of BeiGene from 2016 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$1.49-0.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.22-6.92%๐Ÿ‡บ๐Ÿ‡ธ USA